Correlation between Very Low-Density Lipoprotein and Trygliseride with Glycated Hemoglobin Levels in Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.24293/ijcpml.v28i1.1744Keywords:
Lipid profile, correlation, diabetes, triglycerideAbstract
Patients with Type 2 Diabetes Mellitus (T2DM) have an increased prevalence of dyslipidemia, which contributes to a higher risk of dyslipidemia- related complications in T2DM such as cardiovascular disease and stroke. This study aimed to determine the correlation between TG and VLDL-C towards HbA1c levels in a person with T2DM. A retrospective study of 74 outpatients with T2DM at Sanglah General Hospital, Denpasar, who examined serum HbA1c and lipid profiles were traced for serum TG. From the obtained TG profile, a secondary calculation of VLDL was carried out using the Friedewald equation (TG/5). A correlation test was used to determine the relationship between TG and VLDL-C towards HbA1c levels. Serum TG (212.95±147.46 mg/dL) and VLDL (36.69±23.54 mg/dL) were found to be higher in the group with poor glycemic control (HbA1c > 7 mg/dL) compared to serum TG (111.00±39.56 mg/dL) and VLDL (21.05±6.13 mg/dL) in the group with good glycemic control (HbA1c ≤ 7 mg/dL) (p < 0.05). A positive correlation between serum TG (r=0.512; p < 0.001) and VLDL (r=0.18; p <0.001) towards HbA1c levels in T2DM patient was found. Insulin resistance increases the production of VLDL and ApoC-III in the liver and increased chylomicron absorption in the gastrointestinal tract, causing prolonged post-prandial lipemia and disruption of VLDL and TG clearance, thereby resulting in increased TG and VLDL in circulation. There is a significant positive correlation between serum TG and VLDL towards HbA1c levels in a patient with T2DM.
Downloads
References
Begum A, Irfan SR, Hoque MR, Habib SH, Parvin S, et al. Relationship between HbA1c and lipid profile seen in Bangladesh type 2 diabetes mellitus patients attending BIRDEM Hospital: A cross-sectional study. Mymensingh Med J, 2019; 28(1): 91-95.
Shahwan MJ, Jairoun AA, Farajallah A, Shanabli S. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes Metabolic Syndrome, 2019; 13(4): 2387-2392.
Levitt Katz LE, Bacha F, Gidding SS, Weinstock RS, El Ghormli L, et al. Lipid profiles, inflammatory markers, and insulin therapy in youth with type 2 diabetes. J Pediatric, 2018; 196: 208-216.e2.
Davis PJ, Liu M, Sherman S, Natarajan S, Alemi F, et al. HbA1c, lipid profiles and risk of incident type 2
diabetes in United States Veterans. PLos One, 2018; 13(9): e0203484.
Sunjaya AP, Sunjaya AF. Glycated hemoglobin targets and glycemic control: Link with lipid, uric acid and kidney profile. Diabetes Metabolic Syndrome, 2018; 12(5): 743-748.
Rahmoun MN, Ghembaza CE, El-Amine Ghembaza M. Lipid profile in type 2 patients with diabetes from Tlemcen: A Western Algerian population. Diabetes Metabolic Syndrome, 2019; 13(2): 1347-1351.
Naqvi S, Naveed S, Ali Z, Ahmad SM, Asadullah Khan R, et al. Correlation between glycated hemoglobin and triglyceride level in type 2 diabetes mellitus. Cureus, 2017; 9(6): e1347.
Calanna S, Scicali R, Di Pino A, Knop FK, Piro S, Rabuazzo AM, Purrello F. Lipid and liver abnormalities
in haemoglobin A1c-defined prediabetes and type 2 diabetes. Nutrition Metabolic Cardiovascular Disease, 2014; 24(6): 670-6.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2010;
(Suppl 1): S62-9.
Artha IMJR, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag, 2019; 15: 149-157.
Battacharjee P, Das P, Nath BK, Basumatary A, Das D. HbA1c and its correlation with lipid profile in acute myocardial infarction. International Journal of Contemporary Medical Research, 2018; 5(4): D13-D16.
Reaven P, Merat S, Casanada F, Sutphin M, Palinski W. Effect of streptozocin-induced hyperglycemia in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Atherioscler Thromb Vasc
Biol, 1997; 17(10): 2250-2256.
Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb, 2018; 25(9): 771-782.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab, 2009;
(3): 150-9.
Burtis CA, David E. Tietz fundamental of clinical chemistry and molecular diagnostics. Seventh Ed., USA, Elsevier, 2015; 376.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.